718
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Hesperetin’s health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations

ORCID Icon, , , , , , , , , , , , & ORCID Icon show all

References

  • Abhinav, M., J. Neha, G. Anne, and V. Bharti. 2016. Role of novel drug delivery systems in bioavailability enhancement: At a glance. International Journal of Drug Delivery Technology 6 (1):7–26. doi: 10.25258/ijddt.v6i1.8884.
  • Adelli, G. R., T. Hingorani, N. Punyamurthula, S. P. Balguri, and S. Majumdar. 2015. Evaluation of topical hesperetin matrix film for back-of-the-eye delivery. European Journal of Pharmaceutics and Biopharmaceutics 92:74–82. doi: 10.1016/j.ejpb.2015.02.006.
  • Adhikari-Devkota, A., S. M. I. Elbashir, T. Watanabe, and H. P. Devkota. 2019. Chemical constituents from the flowers of Satsuma mandarin and their free radical scavenging and α-glucosidase inhibitory activities. Natural Product Research 33 (11):1670–3. doi: 10.1080/14786419.2018.1425856.
  • Aizawa, Y., S. Sunada, H. Hirakawa, A. Fujimori, T. A. Kato, and M. Uesaka. 2018. Design and evaluation of a novel flavonoid-based radioprotective agent utilizing monoglucosyl rutin. Journal of Radiation Research 59 (3):272–81. doi: 10.1093/jrr/rrx090.
  • Alshatwi, A. A., E. Ramesh, V. S. Periasamy, and P. Subash-Babu. 2013. The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways. Fundamental & Clinical Pharmacology 27 (6):581–92. doi: 10.1111/j.1472-8206.2012.01061.x.
  • Amakura, Y., T. Tsutsumi, M. Nakamura, H. Kitagawa, J. Fujino, K. Sasaki, M. Toyoda, T. Yoshida, and T. Maitani. 2003. Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biological & Pharmaceutical Bulletin 26 (4):532–9. doi: 10.1248/bpb.26.532.
  • Amaretti, A., S. Raimondi, A. Leonardi, A. Quartieri, and M. Rossi. 2015. Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria. Nutrients 7 (4):2788–800. doi: 10.3390/nu7042788.
  • Anand, D. A. V., R. Arulmoli, and S. Parasuraman. 2016. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacognosy Reviews 10 (20):84–9. doi: 10.4103/0973-7847.194044.
  • Antunes, M. S., A. T. Goes, S. P. Boeira, M. Prigol, and C. R. Jesse. 2014. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice. Nutrition 30 (11-12):1415–22. doi: 10.1016/j.nut.2014.03.024.
  • Aptekmann, N. P., and T. B. Cesar. 2010. Orange juice improved lipid profile and blood lactate of overweight middle-aged women subjected to aerobic training. Maturitas 67 (4):343–7. doi: 10.1016/j.maturitas.2010.07.009.
  • Aranganathan, S., J. P. Selvam, and N. Nalini. 2008. Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: A dose-dependent study. Journal of Pharmacy and Pharmacology 60 (10):1385–92. doi: 10.1211/jpp/60.10.0015.
  • Ashafaq, M., L. Varshney, M. H. Khan, M. Salman, M. Naseem, S. Wajid, and S. Parvez. 2014. Neuromodulatory effects of hesperidin in mitigating oxidative stress in streptozotocin induced diabetes. BioMed Research International 2014:249031. doi: 10.1155/2014/249031.
  • Avila-Galvez, M. A., J. C. Espin, and A. Gonzalez-Sarrias. 2018. Physiological relevance of the antiproliferative and estrogenic effects of dietary polyphenol aglycones versus their phase-II metabolites on breast cancer cells: A call of caution. Journal of Agricultural and Food Chemistry 66 (32):8547–55.
  • Babukumar, S., V. Vinothkumar, P. Velu, and D. Ramachandhiran. 2018. Hesperetin on cell surface glycoconjugates abnormalities and immunohistochemical staining with cytokeratin in 7,12 dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis. Indian Journal of Clinical Biochemistry 33 (4):438–44. doi: 10.1007/s12291-017-0704-z.
  • Bai, X., P. Yang, Q. Zhou, B. Cai, M. Buist-Homan, H. Cheng, J. Jiang, D. Shen, L. Li, X. Luo, et al. 2017. The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro. British Journal of Pharmacology 174 (1):41–56. doi: 10.1111/bph.13645.
  • Bansal, T., A. Awasthi, M. Jaggi, R. K. Khar, and S. Talegaonkar. 2008. Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein. Life Sciences 83 (7-8):250–9. doi: 10.1016/j.lfs.2008.06.007.
  • Başoğlu, M. S., E. Eren, H. Aslan, A. G. Bingölballı, S. Öztürkcan, and H. Katılmış. 2012. Prevention of cisplatin ototoxicity: Efficacy of micronized flavonoid fraction in a guinea pig model. International Journal of Pediatric Otorhinolaryngology 76 (9):1343–6. doi: 10.1016/j.ijporl.2012.06.003.
  • Bawazeer, N. A., H. Choudhry, M. A. Zamzami, W. H. Abdulaal, B. Middleton, and S. S. Moselhy. 2016. Role of hesperetin in LDL-receptor expression in hepatoma HepG2 cells. BMC Complementary and Alternative Medicine 16 (1):182. doi: 10.1186/s12906-016-1165-2.
  • Brash, D. E., and P. Havre. 2002. New careers for antioxidants. Proceedings of the National Academy of Sciences of the United States of America 99 (22):13969–71. doi: 10.1073/pnas.232574399.
  • Breinholt, V. M., E. A. Offord, C. Brouwer, S. E. Nielsen, K. Brosen, and T. Friedberg. 2002. In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food and Chemical Toxicology 40 (5):609–16. doi: 10.1016/S0278-6915(01)00125-9.
  • Buscemi, S., G. Rosafio, G. Arcoleo, A. Mattina, B. Canino, M. Montana, S. Verga, and G. Rini. 2012. Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. The American Journal of Clinical Nutrition 95 (5):1089–95. doi: 10.3945/ajcn.111.031088.
  • Cesar, T. B., N. P. Aptekmann, M. P. Araujo, C. C. Vinagre, and R. C. Maranhao. 2010. Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects. Nutrition Research 30 (10):689–94. doi: 10.1016/j.nutres.2010.09.006.
  • Chanet, A., D. Milenkovic, S. Claude, J. A. Maier, M. Kamran Khan, N. Rakotomanomana, S. Shinkaruk, A. M. Berard, C. Bennetau-Pelissero, A. Mazur, et al. 2013. Flavanone metabolites decrease monocyte adhesion to TNF-α-activated endothelial cells by modulating expression of atherosclerosis-related genes. The British Journal of Nutrition 110 (4):587–98. doi: 10.1017/S0007114512005454.
  • Chen, C. N., C. P. Lin, K. K. Huang, W. C. Chen, H. P. Hsieh, P. H. Liang, and J. T. Hsu. 2005. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3). Evidence-Based Complementary and Alternative Medicine 2 (2):209–15. doi: 10.1093/ecam/neh081.
  • Chen, L., Z. Li, Y. Tang, X. Cui, R. Luo, S. Guo, Y. Zheng, and C. Huang. 2011. Isolation, identification and antiviral activities of metabolites of calycosin-7-O-β-D-glucopyranoside. Journal of Pharmaceutical and Biomedical Analysis 56 (2):382–9. doi: 10.1016/j.jpba.2011.05.033.
  • Chen, Y. C., S. C. Shen, and H. Y. Lin. 2003. Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids. Biochemical Pharmacology 66 (7):1139–50. doi: 10.1016/S0006-2952(03)00455-6.
  • Chen, Y. J., L. Kong, Z. Z. Tang, Y. M. Zhang, Y. Liu, T. Y. Wang, and Y. W. Liu. 2019. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 111:1166–75. doi: 10.1016/j.biopha.2019.01.030.
  • Choi, E. J., and G. H. Kim. 2011. Anti-/pro-apoptotic effects of hesperetin against 7,12-dimetylbenz(a)anthracene-induced alteration in animals. Oncology Reports 25 (2):545–50. doi: 10.3892/or.2010.1105.
  • Constans, J., C. Bennetau-Pelissero, J. F. Martin, E. Rock, A. Mazur, A. Bedel, C. Morand, and A. M. Berard. 2015. Marked antioxidant effect of orange juice intake and its phytomicronutrients in a preliminary randomized cross-over trial on mild hypercholesterolemic men. Clinical Nutrition 34 (6):1093–100. doi: 10.1016/j.clnu.2014.12.016.
  • Costa, I. M., F. O. V. Lima, L. C. B. Fernandes, B. Norrara, F. I. Neta, R. D. Alves, J. Cavalcanti, E. E. S. Lucena, J. S. Cavalcante, A. C. M. Rego, et al. 2019. Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: A systematic review. Current Neuropharmacology 17 (7):648–65. doi: 10.2174/1570159X16666180911123341.
  • D’Archivio, M., C. Filesi, R. D. Benedetto, R. Gargiulo, C. Giovannini, and R. Masella. 2007. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43 (4):348–61.
  • Del Rio, D., A. Rodriguez-Mateos, J. P. Spencer, M. Tognolini, G. Borges, and A. Crozier. 2013. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & Redox Signaling 18 (14):1818–92. doi: 10.1089/ars.2012.4581.
  • Devasagayam, T., J. Tilak, K. Boloor, K. S. Sane, S. S. Ghaskadbi, and R. Lele. 2004. Free radicals and antioxidants in human health: Current status and future prospects. Japi 52 (794804):4.
  • Devyatov, A. A., T. N. Fedorova, D. S. Berezhnoy, S. L. Stvolinskii, and V. A. Tutelyan. 2020. Mechanisms of neuroprotective action of hesperetin and carnosine in focal ischemia of the brain in rats. Bulletin of Experimental Biology and Medicine 169 (2):242–5. doi: 10.1007/s10517-020-04859-w.
  • Ersoz, M., A. Erdemir, D. Duranoglu, D. Uzunoglu, T. Arasoglu, S. Derman, and B. Mansuroglu. 2019. Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 47 (1):319–29. doi: 10.1080/21691401.2018.1556213.
  • Farzaei, M. H., Z. Shahpiri, R. Bahramsoltani, M. M. Nia, F. Najafi, and R. Rahimi. 2017. Efficacy and tolerability of phytomedicines in multiple sclerosis patients: A review. CNS Drugs 31 (10):867–89. doi: 10.1007/s40263-017-0466-4.
  • Francis, S. H., M. D. Houslay, and M. Conti. 2011. Phosphodiesterase inhibitors: Factors that influence potency, selectivity, and action. Handbook of Experimental Pharmacology, (204):47–84.doi: 10.1007/978-3-642-17969-3_2.
  • Furtado, A. F., M. A. Nunes, and M. H. Ribeiro. 2012. Hesperidinase encapsulation towards hesperitin production targeting improved bioavailability. Journal of Molecular Recognition 25 (11):595–603. doi: 10.1002/jmr.2224.
  • Gimenez-Bastida, J. A., A. Gonzalez-Sarrias, F. Vallejo, J. C. Espin, and F. A. Tomas-Barberan. 2016. Hesperetin and its sulfate and glucuronide metabolites inhibit TNF-α induced human aortic endothelial cell migration and decrease plasminogen activator inhibitor-1 (PAI-1) levels. Food & Function 7 (1):118–26. doi: 10.1039/c5fo00771b.
  • González-Alfonso, J. L., N. Míguez, J. Padilla, L. Leemans, A. Poveda, J. Jiménez-Barbero, A. Ballesteros, G. Sandoval, and F. Plou. 2018. Optimization of regioselective α-glucosylation of hesperetin catalyzed by cyclodextrin glucanotransferase. Molecules 23 (11):2885. doi: 10.3390/molecules23112885.
  • Habauzit, V., I. L. Nielsen, A. Gil-Izquierdo, A. Trzeciakiewicz, C. Morand, W. Chee, D. Barron, P. Lebecque, M. J. Davicco, G. Williamson, et al. 2009. Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats. British Journal of Nutrition 102 (7):976–84. doi: 10.1017/S0007114509338830.
  • Haghmorad, D., M. B. Mahmoudi, Z. Salehipour, Z. Jalayer, A. A. Momtazi Brojeni, M. Rastin, P. Kokhaei, and M. Mahmoudi. 2017. Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis. Journal of Neuroimmunology 302:23–33. doi: 10.1016/j.jneuroim.2016.11.009.
  • Hajialyani, M., M. Hosein Farzaei, J. Echeverria, S. M. Nabavi, E. Uriarte, and E. Sobarzo-Sanchez. 2019. Hesperidin as a neuroprotective agent: A review of animal and clinical evidence. Molecules 24 (3):648. doi: 10.3390/molecules24030648.
  • He, P., J. Ma, Y. Liu, H. Deng, and W. Dong. 2020. Hesperetin promotes cisplatin-induced apoptosis of gastric cancer in vitro and in vivo by upregulating PTEN expression. Frontiers in Pharmacology 11:1326. doi: 10.3389/fphar.2020.01326.
  • Hoek-van den Hil, E. F., E. M. van Schothorst, I. van der Stelt, H. J. M. Swarts, M. van Vliet, T. Amolo, J. J. M. Vervoort, D. Venema, P. C. H. Hollman, I. M. Rietjens, et al. 2015. Direct comparison of metabolic health effects of the flavonoids quercetin, hesperetin, epicatechin, apigenin and anthocyanins in high-fat-diet-fed mice. Genes & Nutrition 10 (4):469. doi: 10.1007/s12263-015-0469-z.
  • Hou, X., Y. Liu, L. Niu, L. Cui, and M. Zhang. 2014. Enhancement of voltage-gated K + channels and depression of voltage-gated Ca2+ channels are involved in quercetin-induced vasorelaxation in rat coronary artery. Planta Medica 80 (6):465–72. doi: 10.1055/s-0034-1368320.
  • Jang, Y., H. M. Sohn, Y. J. Ko, H. Hyun, and W. Lim. 2021. Inhibition of RANKL-induced osteoclastogenesis by novel mutant RANKL. International Journal of Molecular Sciences 22 (1):434. doi: 10.3390/ijms22010434.
  • Jayaraman, R., S. Subramani, S. H. S. Abdullah, and M. Udaiyar. 2018. Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin-induced diabetic rats. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 97:98–106. doi: 10.1016/j.biopha.2017.10.102.
  • Jin, Y. R., X. H. Han, Y. H. Zhang, J. J. Lee, Y. Lim, J. H. Chung, and Y. P. Yun. 2007. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 194 (1):144–52. doi: 10.1016/j.atherosclerosis.2006.10.011.
  • Kakran, M., G. Sahoo, and L. Li. 2015. Fabrication of nanoparticles of silymarin, hesperetin and glibenclamide by evaporative precipitation of nanosuspension for fast dissolution. Pharmaceutica Analytica Acta 6 (326).doi:10.4172/2153-2435.1000326.
  • Kanaze, F. I., M. I. Bounartzi, M. Georgarakis, and I. Niopas. 2007. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. European Journal of Clinical Nutrition 61 (4):472–7. doi: 10.1038/sj.ejcn.1602543.
  • Kang, D. H. 2002. Oxidative stress, DNA damage, and breast cancer. AACN Clinical Issues 13 (4):540–9.
  • Kang, J. A., S. H. Yoon, J. K. Rho, B. S. Jang, D. S. Choi, D. E. Lee, E. B. Byun, J. Jeon, and S. H. Park. 2016. Radioprotective effect of hesperetin against γ-irradiation-induced DNA damage and immune dysfunction in murine splenocytes. Food Science and Biotechnology 25 (Suppl 1):163–8. doi: 10.1007/s10068-016-0114-7.
  • Kara, M., H. Türkön, T. Karaca, O. Güçlü, S. Uysal, M. Türkyılmaz, S. Demirtaş, and F. S. Dereköy. 2016. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model. International Journal of Pediatric Otorhinolaryngology 85:12–8. doi: 10.1016/j.ijporl.2016.03.019.
  • Kara, S., B. Gencer, T. Karaca, H. A. Tufan, S. Arikan, I. Ersan, I. Karaboga, and V. Hanci. 2014. Protective effect of hesperetin and naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats. The Scientific World Journal 2014:1–8. doi: 10.1155/2014/797824.
  • Kean, R. J., D. J. Lamport, G. F. Dodd, J. E. Freeman, C. M. Williams, J. A. Ellis, L. T. Butler, and J. P. Spencer. 2015. Chronic consumption of flavanone-rich orange juice is associated with cognitive benefits: An 8-wk, randomized, double-blind, placebo-controlled trial in healthy older adults. The American Journal of Clinical Nutrition 101 (3):506–14. doi: 10.3945/ajcn.114.088518.
  • Kheradmand, E., A. Hajizadeh Moghaddam, and M. Zare. 2018. Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 97:1096–101. doi: 10.1016/j.biopha.2017.11.047.
  • Kim, H. K., T. S. Jeong, M. K. Lee, Y. B. Park, and M. S. Choi. 2003. Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clinica Chimica Acta 327 (1-2):129–37. doi: 10.1016/S0009-8981(02)00344-3.
  • Kim, J. Y., K. J. Jung, J. S. Choi, and H. Y. Chung. 2006. Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5 (5):401–11. doi: 10.1111/j.1474-9726.2006.00233.x.
  • Ko, W. C., C. M. Shih, Y. H. Lai, J. H. Chen, and H. L. Huang. 2004. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochemical Pharmacology 68 (10):2087–94. doi: 10.1016/j.bcp.2004.06.030.
  • Kometani, T., T. Nishimura, T. Nakae, H. Takii, and S. Okada. 1996. Synthesis of neohesperidin glycosides and naringin glycosides by cyclodextrin glucanotransferase from an alkalophilic Bacillus species. Bioscience, Biotechnology, and Biochemistry 60 (4):645–9. doi: 10.1271/bbb.60.645.
  • Kong, W., X. Ling, Y. Chen, X. Wu, Z. Zhao, W. Wang, S. Wang, G. Lai, and Z. Yu. 2020. Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway. International Journal of Molecular Medicine 45 (4):1213–24. doi: 10.3892/ijmm.2020.4485.
  • Kottaiswamy, A., A. Kizhakeyil, A. M. Padmanaban, F. B. Mirza, V. R. Vijay, P. S. Lee, N. K. Verma, P. Kalaiselvan, and S. Samuel. 2020. The citrus flavanone hesperetin induces apoptosis in CTCL cells via STAT3/Notch1/NFκB-mediated signaling axis. Anti-Cancer Agents in Medicinal Chemistry 20 (12):1459–68. doi: 10.2174/1871521409666200324110031.
  • Kumar, P., and A. Kumar. 2010. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: Possible role of nitric oxide. Behavioural Brain Research 206 (1):38–46. doi: 10.1016/j.bbr.2009.08.028.
  • Kuppusamy, U. R., and N. P. Das. 1992. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochemical Pharmacology 44 (7):1307–15. doi: 10.1016/0006-2952(92)90531-M.
  • Lamport, D. J., D. Pal, A. L. Macready, S. Barbosa-Boucas, J. M. Fletcher, C. M. Williams, J. P. Spencer, and L. T. Butler. 2016. The effects of flavanone-rich citrus juice on cognitive function and cerebral blood flow: An acute, randomised, placebo-controlled cross-over trial in healthy, young adults. The British Journal of Nutrition 116 (12):2160–8. doi: 10.1017/S000711451600430X.
  • Lee, J., D. H. Kim, and J. H. Kim. 2019. Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway. Phytomedicine 58:152762. doi: 10.1016/j.phymed.2018.11.022.
  • Lee, S., K. Youn, G. T. Lim, J. Lee, and M. Jun. 2018. In silico docking and in vitro approaches towards BACE1 and cholinesterases inhibitory effect of citrus flavanones. Molecules 23 (7):1509. doi: 10.3390/molecules23071509.
  • Lentini, A., C. Forni, B. Provenzano, and S. Beninati. 2007. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential. Amino Acids 32 (1):95–100. doi: 10.1007/s00726-006-0304-3.
  • Lepik, D., V. Jaks, L. Kadaja, S. Varv, and T. Maimets. 2003. Electroporation and carrier DNA cause p53 activation, cell cycle arrest, and apoptosis. Analytical Biochemistry 318 (1):52–9. doi: 10.1016/S0003-2697(03)00135-0.
  • Li, Q., Z. Miao, R. Wang, J. Yang, and D. Zhang. 2020. Hesperetin induces apoptosis in human glioblastoma cells via p38 MAPK activation. Nutrition and Cancer 72 (3):538–45. doi: 10.1080/01635581.2019.1638424.
  • Li, R., L. Cai, X. F. Xie, L. Peng, T. N. Wu, and J. Li. 2013. 7,3'-dimethoxy hesperetin inhibits inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis. Immunopharmacology and Immunotoxicology 35 (1):139–46. doi: 10.3109/08923973.2012.723010.
  • Lin, C. C., C. H. Yang, Y. J. Lin, Y. W. Chiu, and C. Y. Chen. 2015. Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells. Enzyme and Microbial Technology 68:1–9. doi: 10.1016/j.enzmictec.2014.09.008.
  • Lin, C. W., F. J. Tsai, C. H. Tsai, C. C. Lai, L. Wan, T. Y. Ho, C. C. Hsieh, and P. D. Chao. 2005. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Research 68 (1):36–42. doi: 10.1016/j.antiviral.2005.07.002.
  • Liu, Y., L. Niu, L. Cui, X. Hou, J. Li, X. Zhang, and M. Zhang. 2014. Hesperetin inhibits rat coronary constriction by inhibiting Ca(2+) influx and enhancing voltage-gated K(+) channel currents of the myocytes. European Journal of Pharmacology 735:193–201. doi: 10.1016/j.ejphar.2014.03.057.
  • Magiera, S., I. Baranowska, and A. Lautenszleger. 2015. UHPLC-UV method for the determination of flavonoids in dietary supplements and for evaluation of their antioxidant activities. Journal of Pharmaceutical and Biomedical Analysis 102:468–75. doi: 10.1016/j.jpba.2014.10.004.
  • Manach, C., A. Scalbert, C. Morand, C. Remesy, and L. Jimenez. 2004. Polyphenols: Food sources and bioavailability. The American Journal of Clinical Nutrition 79 (5):727–47. doi: 10.1093/ajcn/79.5.727.
  • Meiyanto, E., A. Hermawan, and Anindyajati. 2012. Natural products for cancer-targeted therapy: Citrus flavonoids as potent chemopreventive agents. Asian Pacific Journal of Cancer Prevention 13 (2):427–36. doi: 10.7314/apjcp.2012.13.2.427.
  • Mendel, M., M. Chłopecka, N. Dziekan, and W. Karlik. 2016. Antispasmodic effect of selected Citrus flavonoids on rat isolated jejunum specimens. European Journal of Pharmacology 791:640–6. doi: 10.1016/j.ejphar.2016.10.006.
  • Morand, C., C. Dubray, D. Milenkovic, D. Lioger, J. F. Martin, A. Scalbert, and A. Mazur. 2011. Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. The American Journal of Clinical Nutrition 93 (1):73–80. doi: 10.3945/ajcn.110.004945.
  • Muhammad, T., M. Ikram, R. Ullah, S. U. Rehman, and M. O. Kim. 2019. Hesperetin, a Citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-kappaB signaling. Nutrients 11 (3):648. doi: 10.3390/nu11030648.
  • Mukherjee, K., K. Maiti, M. Venkatesh, and P. K. Mukherjee. 2008. Phytosome of hesperetin, a value added formulation with phytomolecules. 60th Indian Pharmaceutical Congress, New Delhi.
  • Mursu, J., S. Voutilainen, T. Nurmi, T.-P. Tuomainen, S. Kurl, and J. T. Salonen. 2008. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. The British Journal of Nutrition 100 (4):890–5. doi: 10.1017/S0007114508945694.
  • Musa, A. E., G. Omyan, F. Esmaely, and D. Shabeeb. 2019. Radioprotective effect of hesperidin: A systematic review. Medicina 55 (7):370. doi: 10.3390/medicina55070370.
  • Nabavi, S. F., A. Sureda, A. R. Dehpour, S. Shirooie, A. S. Silva, K. P. Devi, T. Ahmed, N. Ishaq, R. Hashim, E. Sobarzo-Sanchez, et al. 2018. Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration. Biotechnology Advances 36 (6):1768–78. doi: 10.1016/j.biotechadv.2017.12.001.
  • Nielsen, I. L. F., W. S. S. Chee, L. Poulsen, E. Offord-Cavin, S. E. Rasmussen, H. Frederiksen, M. Enslen, D. Barron, M.-N. Horcajada, and G. Williamson. 2006. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double-blind, crossover trial. The Journal of Nutrition 136 (2):404–8. doi: 10.1093/jn/136.2.404.
  • Noshita, T., A. Tai, T. Matsumoto, K. Miura, K. Ikeda, and Y. Hamada. 2017. Structure-activity relationship of flavanone. Anti-degranulation activity of 7-O-substituted hesperetin. Natural Product Research 31 (18):2137–42. doi: 10.1080/14786419.2017.1280486.
  • Pandey, K. B., and S. I. Rizvi. 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity 2 (5):270–8. doi: 10.4161/oxim.2.5.9498.
  • Paramita, P., S. N. Sethu, N. Subhapradha, V. Ragavan, R. Ilangovan, A. Balakrishnan, N. Srinivasan, R. Murugesan, and A. Moorthi. 2020. Neuro-protective effects of nano-formulated hesperetin in a traumatic brain injury model of Danio rerio. Drug and Chemical Toxicology, 1–8.doi: 10.1080/01480545.2020.1722690
  • Parhiz, H., A. Roohbakhsh, F. Soltani, R. Rezaee, and M. Iranshahi. 2015. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytotherapy Research 29 (3):323–31. doi: 10.1002/ptr.5256.
  • Park, M., H. D. Chae, J. Yun, M. Jung, Y. S. Kim, S. H. Kim, M. H. Han, and D. Y. Shin. 2000. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Research 60 (3):542–5.
  • Patel, K., and D. K. Patel. 2017. Medicinal importance, pharmacological activities, and analytical aspects of hispidulin: A concise report. Journal of Traditional and Complementary Medicine 7 (3):360–6. doi: 10.1016/j.jtcme.2016.11.003.
  • Pereira-Caro, G., T. Polyviou, I. A. Ludwig, A. M. Nastase, J. M. Moreno-Rojas, A. L. Garcia, D. Malkova, and A. Crozier. 2017. Bioavailability of orange juice (poly)phenols: The impact of short-term cessation of training by male endurance athletes. The American Journal of Clinical Nutrition 106 (3):791–800. doi: 10.3945/ajcn.116.149898.
  • Qin, X. Y., Y. Cheng, and L. C. Yu. 2012. Potential protection of green tea polyphenols against intracellular amyloid beta-induced toxicity on primary cultured prefrontal cortical neurons of rats. Neuroscience Letters 513 (2):170–3. doi: 10.1016/j.neulet.2012.02.029.
  • Rainey-Smith, S., L. W. Schroetke, P. Bahia, A. Fahmi, R. Skilton, J. P. Spencer, C. Rice-Evans, M. Rattray, and R. J. Williams. 2008. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation. Neuroscience Letters 438 (1):29–33. doi: 10.1016/j.neulet.2008.04.056.
  • Rangel-Huerta, O. D., C. M. Aguilera, M. V. Martin, M. J. Soto, M. C. Rico, F. Vallejo, F. Tomas-Barberan, A. J. Perez-de-la-Cruz, A. Gil, and M. D. Mesa. 2015. Normal or high polyphenol concentration in orange juice affects antioxidant activity, blood pressure, and body weight in obese or overweight adults. The Journal of Nutrition 145 (8):1808–16. doi: 10.3945/jn.115.213660.
  • Rasouli, H., S. M. Hosseini-Ghazvini, H. Adibi, and R. Khodarahmi. 2017. Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: A virtual screening perspective for the treatment of obesity and diabetes. Food & Function 8 (5):1942–54. doi: 10.1039/c7fo00220c.
  • Rizza, S., R. Muniyappa, M. Iantorno, J. A. Kim, H. Chen, P. Pullikotil, N. Senese, M. Tesauro, D. Lauro, C. Cardillo, et al. 2011. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. The Journal of Clinical Endocrinology and Metabolism 96 (5):E782–792. doi: 10.1210/jc.2010-2879.
  • Rosas, H. D., S. Y. Lee, A. C. Bender, A. K. Zaleta, M. Vangel, P. Yu, B. Fischl, V. Pappu, C. Onorato, J. H. Cha, et al. 2010. Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection". Neuroimage 49 (4):2995–3004. doi: 10.1016/j.neuroimage.2009.10.015.
  • Rusznyak, S., and A. Szent-Gyorgyi. 1936. Vitamin P: Flavonols as vitamins. Nature 138 (3479):27.
  • Salden, B. N., F. J. Troost, E. de Groot, Y. R. Stevens, M. Garces-Rimon, S. Possemiers, B. Winkens, and A. A. Masclee. 2016. Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals. The American Journal of Clinical Nutrition 104 (6):1523–1533. doi: 10.3945/ajcn.116.136960.
  • Salem, H. R. A., A. El-Raouf, E. M. Saleh, and K. A. Shalaby. 2012. Influence of hesperidin combined with Sinemet on genetical and biochemical abnormalities in rats suffering from Parkinson’s disease. Life Science Journal 9:930–945.
  • Samie, A., R. Sedaghat, T. Baluchnejadmojarad, and M. Roghani. 2018. Hesperetin, a citrus flavonoid, attenuates testicular damage in diabetic rats via inhibition of oxidative stress, inflammation, and apoptosis. Life Sciences 210:132–139. doi: 10.1016/j.lfs.2018.08.074.
  • Sangpheak, W., J. Kicuntod, R. Schuster, T. Rungrotmongkol, P. Wolschann, N. Kungwan, H. Viernstein, M. Mueller, and P. Pongsawasdi. 2015. Physical properties and biological activities of hesperetin and naringenin in complex with methylated β-cyclodextrin. Beilstein Journal of Organic Chemistry 11:2763–2773. doi: 10.3762/bjoc.11.297.
  • Santhakumar, A. B., M. Battino, and J. M. Alvarez-Suarez. 2018. Dietary polyphenols: Structures, bioavailability and protective effects against atherosclerosis. Food and Chemical Toxicology 113:49–65. doi: 10.1016/j.fct.2018.01.022.
  • Scholz, N. 2015. Medicinal products in the European Union. European Parliamentary Research Service.
  • Shih, C. H., L. H. Lin, H. T. Hsu, K. H. Wang, C. Y. Lai, C. M. Chen, and W. C. Ko. 2012. Hesperetin, a selective phosphodiesterase 4 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without influencing xylazine/ketamine-induced anesthesia. Evidence-Based Complementary and Alternative Medicine 2012:472897. doi: 10.1155/2012/472897.
  • Shih, C. H., W. H. Wang, C. M. Chen, and W. C. Ko. 2020. Hesperetin-5,7,3'-O-trimethylether dually inhibits phosphodiesterase 3/4 and methacholine-induced airway hyperresponsiveness in sensitized and challenged mice. Drug Design, Development and Therapy 14:519–526. doi: 10.2147/DDDT.S227432.
  • Shimoi, K., and T. Nakayama. 2005. Glucuronidase deconjugation in inflammation. Methods in Enzymology 400:263–272. doi: 10.1016/S0076-6879(05)00015-7.
  • Shirzad, M., E. Heidarian, P. Beshkar, and M. Gholami-Arjenaki. 2017. Biological effects of hesperetin on Interleukin-6/phosphorylated signal transducer and activator of transcription 3 pathway signaling in prostate cancer PC3 cells. Pharmacognosy Research 9 (2):188.
  • Si-Ahmed, K., T. Fairouz, A. Y. Badjah-Hadj-Ahmed, A. Zeineb, G. D’Orazio, A. Rocco, and S. Fanali. 2010. Analysis of hesperetin enantiomers in human urine after ingestion of blood orange juice by using nano-liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 51 (1):225–229. doi: 10.1016/j.jpba.2009.08.015.
  • Smina, T. P., A. Mohan, K. A. Ayyappa, S. Sethuraman, and U. M. Krishnan. 2015. Hesperetin exerts apoptotic effect on A431 skin carcinoma cells by regulating mitogen activated protein kinases and cyclins. Cellular and Molecular Biology 61 (6):92–99.
  • Soldati, L., L. Di Renzo, E. Jirillo, P. A. Ascierto, F. M. Marincola, and A. D. Lorenzo. 2018. The influence of diet on anti-cancer immune responsiveness. Journal of Translational Medicine 16 (1):75. doi: 10.1186/s12967-018-1448-0.
  • Somerset, S. M., and L. Johannot. 2008. Dietary flavonoid sources in Australian adults. Nutrition and Cancer 60 (4):442–449. doi: 10.1080/01635580802143836.
  • Souza, L. C., M. G. de Gomes, A. T. Goes, L. Del Fabbro, C. B. Filho, S. P. Boeira, and C. R. Jesse. 2013. Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 40:103–109. doi: 10.1016/j.pnpbp.2012.09.003.
  • Spanakis, M., S. Kasmas, and I. Niopas. 2009. Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: In vivo metabolic reduction of diosmetin to hesperetin. Biomedical Chromatography 23 (2):124–131. doi: 10.1002/bmc.1092.
  • Stanisic, D., A. F. Costa, W. J. Fávaro, L. Tasic, A. B. Seabra, and N. Duran. 2018. Anticancer activities of hesperidin and hesperetin in vivo and their potentiality against bladder cancer. Journal ofNanomedicine & Nanotechnology 9 (5).doi: 10.4172/2157-7439.1000515.
  • Straub, I., F. Mohr, J. Stab, M. Konrad, S. E. Philipp, J. Oberwinkler, and M. Schaefer. 2013. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3. British Journal of Pharmacology 168 (8):1835–1850. doi: 10.1111/bph.12076.
  • Sucher, N. J., and M. C. Carles. 2015. A pharmacological basis of herbal medicines for epilepsy. Epilepsy & Behavior 52 (Pt B):308–318. doi: 10.1016/j.yebeh.2015.05.012.
  • Takumi, H., N. Fujishima, K. Shiraishi, Y. Mori, A. Ariyama, T. Kometani, S. Hashimoto, and T. Nadamoto. 2010. Effects of alpha-glucosylhesperidin on the peripheral body temperature and autonomic nervous system. Bioscience, Biotechnology, and Biochemistry 74 (4):707–715. doi: 10.1271/bbb.90742.
  • Tian, Q., E. G. Miller, H. Ahmad, L. Tang, and B. S. Patil. 2001. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutrition and Cancer 40 (2):180–184. doi: 10.1207/S15327914NC402_15.
  • Tong, L., Z. Dandan, G. Jun, Z. Yonghong, S. He, and B. Kaishun. 2012. Simultaneous determination of naringin, hesperidin, neohesperidin, naringenin and hesperetin of Fractus aurantii extract in rat plasma by liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 58 (25):58–64. doi: 10.1016/j.jpba.2011.05.001.
  • Tsimoyiannis, E. C., G. Floras, N. Antoniou, N. Papanikolaou, P. Siakas, and A. Tassis. 1996. Low-molecular-weight heparins and Daflon for prevention of postoperative thromboembolism. World Journal of Surgery 20 (8):968–972. doi: 10.1007/s002689900145.
  • Valko, M., C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 160 (1):1–40. doi: 10.1016/j.cbi.2005.12.009.
  • Vallejo, F., M. Larrosa, E. Escudero, M. P. Zafrilla, B. Cerdá, J. Boza, M. T. García-Conesa, J. C. Espín, and F. A. Tomás-Barberán. 2010. Concentration and solubility of flavanones in orange beverages affect their bioavailability in humans. Journal of Agricultural and Food Chemistry 58 (10):6516–6524. doi: 10.1021/jf100752j.
  • Visnagri, A., A. D. Kandhare, S. Chakravarty, P. Ghosh, and S. L. Bodhankar. 2014. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharmaceutical Biology 52 (7):814–828. doi: 10.3109/13880209.2013.870584.
  • Vogiatzoglou, A., A. A. Mulligan, M. A. Lentjes, R. N. Luben, J. P. Spencer, H. Schroeter, K. T. Khaw, and G. G. Kuhnle. 2015. Flavonoid intake in European adults (18 to 64 years). PLoS One 10 (5):e0128132. doi: 10.1371/journal.pone.0128132.
  • Wang, B., L. Li, P. Jin, M. Li, and J. Li. 2017. Hesperetin protects against inflammatory response and cardiac fibrosis in postmyocardial infarction mice by inhibiting nuclear factor κB signaling pathway. Experimental & Therapeutic Medicine.14(3): 2255–2260. doi: 10.3892/etm.2017.4729.
  • Wang, D., L. Liu, X. Zhu, W. Wu, and Y. Wang. 2014. Hesperidin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress in a mouse model of Alzheimer's disease. Cellular and Molecular Neurobiology 34 (8):1209–1221. doi: 10.1007/s10571-014-0098-x.
  • Wang, H., H-f Wang, H. Zhang, C. Wang, Y-f Chen, R. Ma, J-z Xiang, X-l Du, and Q. Tang. 2016. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes. Acta Pharmacologica Sinica 37 (12):1563–1573. doi: 10.1038/aps.2016.97.
  • Wang, J., X. Tan, X. Li, J. Liu, and Z. Song. 2012. Determination of hesperetin in pericarpium citri reticulatae and human serum using flow injection chemiluminescence. ISRN Analytical Chemistry 2012:1–5. doi: 10.5402/2012/809256.
  • Wang, S. W., W. Wang, H. Sheng, Y. F. Bai, Y. Y. Weng, X. Y. Fan, F. Zheng, X. T. Zhu, Z. C. Xu, and F. Zhang. 2020. Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/CREB pathway. International Immunopharmacology 89 (Pt B):107036. doi: 10.1016/j.intimp.2020.107036.
  • Williamson, G., C. D. Kay, and A. Crozier. 2018. The bioavailability, transport, and bioactivity of dietary flavonoids: A review from a historical perspective. Comprehensive Reviews in Food Science and Food Safety 17 (5):1054–1112. doi: 10.1111/1541-4337.12351.
  • Wu, Y. W., S. C. Chen, W. F. T. Lai, Y. C. Chen, and Y. H. Tsai. 2013. Screening of flavonoids for effective osteoclastogenesis suppression. Analytical Biochemistry 433 (1):48–55. doi: 10.1016/j.ab.2012.10.008.
  • Yadav, M., S. Jain, A. Bhardwaj, R. Nagpal, M. Puniya, R. Tomar, V. Singh, O. Parkash, G. B. K. S. Prasad, F. Marotta, et al. 2009. Biological and medicinal properties of grapes and their bioactive constituents: An update. Journal of Medicinal Food 12 (3):473–484. doi: 10.1089/jmf.2008.0096.
  • Yamada, M., F. Tanabe, N. Arai, H. Mitsuzumi, Y. Miwa, M. Kubota, H. Chaen, and M. Kibata. 2006. Bioavailability of glucosyl hesperidin in rats. Bioscience, Biotechnology, and Biochemistry 70 (6):1386–1394. doi: 10.1271/bbb.50657.
  • Yamamoto, M., A. Suzuki, and T. Hase. 2008. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. Journal of Nutritional Science and Vitaminology 54 (1):95–98. doi: 10.3177/jnsv.54.95.
  • Yamamoto, M., H. Jokura, K. Hashizume, H. Ominami, Y. Shibuya, A. Suzuki, T. Hase, and A. Shimotoyodome. 2013. Hesperidin metabolite hesperetin-7-O-glucuronide, but not hesperetin-3'-O-glucuronide, exerts hypotensive, vasodilatory, and anti-inflammatory activities. Food & Function 4 (9):1346–1351. doi: 10.1039/c3fo60030k.
  • Yamamoto, M., H. Jokura, A. Suzuki, T. Hase, and A. Shimotoyodome. 2013. Effects of continuous ingestion of hesperidin and glucosyl hesperidin on vascular gene expression in spontaneously hypertensive rats. Journal of Nutritional Science and Vitaminology 59 (5):470–473. doi: 10.3177/jnsv.59.470.
  • Yang, H. L., S. C. Chen, K. J. Senthil Kumar, K. N. Yu, P. D. Lee Chao, S. Y. Tsai, Y. C. Hou, and Y. C. Hseu. 2012. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: An ex vivo approach. Journal of Agricultural and Food Chemistry 60 (1):522–532. doi: 10.1021/jf2040675.
  • Yang, Y. L., C. L. Chen, C. M. Chen, and W. C. Ko. 2017. Hesperetin-5,7,3'-O-triacetate suppresses airway hyperresponsiveness in ovalbumin-sensitized and challenged mice without reversing xylazine/ketamine-induced anesthesia in normal mice. BMC Pharmacology & Toxicology 18 (1):39. doi: 10.1186/s40360-017-0146-5.
  • Yang, Z., Y. Liu, W. Deng, J. Dai, F. Li, Y. Yuan, Q. Wu, H. Zhou, Z. Bian, and Q. Tang. 2014. Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Molecular Medicine Reports 9 (5):1941–1946. doi: 10.3892/mmr.2014.2002.
  • Yáñez, J. A., X. W. Teng, K. A. Roupe, and N. M. Davies. 2005. Stereospecific high-performance liquid chromatographic analysis of hesperetin in biological matrices. Journal of Pharmaceutical and Biomedical Analysis 37 (3):591–595. doi: 10.1016/j.jpba.2004.10.028.
  • Yuan, L., C. Wagatsuma, B. Sun, J. H. Kim, and Y. J. Surh. 2003. The role of beta-glucuronidase in induction of apoptosis by genistein combined polysaccharide (GCP) in xenogeneic mice bearing human mammary cancer cells. Annals of the New York Academy of Sciences 1010:347–349. doi: 10.1196/annals.1299.063.
  • Zamora-Ros, R., C. Andres-Lacueva, R. M. Lamuela-Raventos, T. Berenguer, P. Jakszyn, A. Barricarte, E. Ardanaz, P. Amiano, M. Dorronsoro, N. Larranaga, et al. 2010. Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). Journal of the American Dietetic Association 110 (3):390–398. doi: 10.1016/j.jada.2009.11.024.
  • Zarebczan, B., S. N. Pinchot, M. Kunnimalaiyaan, and H. Chen. 2011. Hesperetin, a potential therapy for carcinoid cancer. American Journal of Surgery 201 (3):329–332, discussion 333. doi: 10.1016/j.amjsurg.2010.08.018.
  • Zhang, J., D. Wu, Vikash, J. Song, J. Wang, J. Yi, and W. Dong. 2015. Hesperetin induces the apoptosis of gastric cancer cells via activating mitochondrial pathway by increasing reactive oxygen species. Digestive Diseases and Sciences 60 (10):2985–2995.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.